ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,275.38
0.54%
Dow Jones
38,686.32
1.51%
Gold vs US Dollar
2,326.785
-0.02%
Brent Oil
81.14
0.41%
Bitcoin
68,275.48
0.78%
Pepperstone
Advertisement
Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. GeoVax Labs Inc (GOVX)

  7. GeoVax Labs Inc (GOVX) News

GeoVax Labs (GOVX)

GeoVax Labs Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:GOVX
DateTimeSourceHeadlineSymbolCompany
04/04/202417:30GlobeNewswire Inc.GeoVax Presents Data on GEO-CM04S1, a Next Generation Covid-19 VaccineNASDAQ:GOVXGeoVax Labs Inc
28/03/202413:00GlobeNewswire Inc.GeoVax to Present Data on GEO-CM04S1, a Next Generation Covid-19 Vaccine, at the World Vaccine CongressNASDAQ:GOVXGeoVax Labs Inc
12/03/202413:00GlobeNewswire Inc.GeoVax to Present at the 36th Annual Roth ConferenceNASDAQ:GOVXGeoVax Labs Inc
11/03/202420:13Edgar (US Regulatory)Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]NASDAQ:GOVXGeoVax Labs Inc
11/03/202404:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:GOVXGeoVax Labs Inc
11/03/202404:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:GOVXGeoVax Labs Inc
11/03/202404:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:GOVXGeoVax Labs Inc
11/03/202404:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:GOVXGeoVax Labs Inc
06/03/202414:00GlobeNewswire Inc.GeoVax Achieves Milestone in Transition to Commercially Validated Manufacturing SystemNASDAQ:GOVXGeoVax Labs Inc
01/03/202421:08Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:GOVXGeoVax Labs Inc
29/02/202421:05Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:GOVXGeoVax Labs Inc
29/02/202421:00GlobeNewswire Inc.GeoVax Reports 2023 Year-End Financial Results and Provides Business UpdateNASDAQ:GOVXGeoVax Labs Inc
22/02/202421:41Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GOVXGeoVax Labs Inc
22/02/202414:00GlobeNewswire Inc.GeoVax to Report 2023 Financial Results and Provide Corporate Update on February 29, 2024NASDAQ:GOVXGeoVax Labs Inc
19/02/202414:00GlobeNewswire Inc.GeoVax to Present at the 2024 BIO CEO & Investor ConferenceNASDAQ:GOVXGeoVax Labs Inc
16/02/202421:01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:GOVXGeoVax Labs Inc
14/02/202420:38Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:GOVXGeoVax Labs Inc
13/02/202414:00GlobeNewswire Inc.GeoVax Announces Multiple Patent Issuances and AllowancesNASDAQ:GOVXGeoVax Labs Inc
07/02/202421:43Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GOVXGeoVax Labs Inc
06/02/202414:00GlobeNewswire Inc.GeoVax Reports Positive Interim Data From Phase 2 Clinical Trial of GEO-CM04S1 as a Universal Covid-19 Vaccine BoosterNASDAQ:GOVXGeoVax Labs Inc
31/01/202418:13Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:GOVXGeoVax Labs Inc
29/01/202414:00GlobeNewswire Inc.GeoVax Announces 1-for-15 Reverse Stock Split to Regain Compliance with Nasdaq Minimum Bid RequirementNASDAQ:GOVXGeoVax Labs Inc
16/01/202421:03Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:GOVXGeoVax Labs Inc
12/01/202421:00Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:GOVXGeoVax Labs Inc
12/01/202405:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:GOVXGeoVax Labs Inc
08/01/202414:00GlobeNewswire Inc.GeoVax Appoints Dr. Marc Pipas as Executive Medical Director, OncologyNASDAQ:GOVXGeoVax Labs Inc
04/01/202414:00GlobeNewswire Inc.GeoVax Announces Gedeptin® Patient Enrollment Closure for Phase 1/2 Clinical Trial Among Advanced Head and Neck Cancer PatientsNASDAQ:GOVXGeoVax Labs Inc
03/01/202414:00GlobeNewswire Inc.GeoVax Announces Issuance of Malaria Vaccine PatentNASDAQ:GOVXGeoVax Labs Inc
02/01/202421:10Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:GOVXGeoVax Labs Inc
27/12/202314:00GlobeNewswire Inc.GeoVax to Present at Biotech Showcase During J.P. Morgan Healthcare Week 2024NASDAQ:GOVXGeoVax Labs Inc
 Showing the most relevant articles for your search:NASDAQ:GOVX

Your Recent History

EU
AACLL
Credit Agricole Cib Fina...
TSX
TPX.A
Molson Coors Canada
USOTC
AMTY
Amerityre (PK)
NYSE
TNP
Tsakos Energy Navigation
NASDAQ
NICE
NICE
NASDAQ
TBOW
NASDAQ
TWKS
Thoughtworks
NYSE
BIO.B
Bio Rad Laboratories
NASDAQ
SMFR
Sema4
TSX
BAM
Brookfield Asset Managem...
LSE
BNT
Basepoint
BOV
RSUL3
RIO SULENSE ON
USOTC
CMRZF
Commerce Resources (QX)
LSE
TEL
Teliti
TSXV
KS
Klondike Silver
LSE
GAS
Gasol
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved